TERN
Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals, Inc. (TERN) has 5 SEC Form 4 filings (7 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: May 5, 2026.
Insiders have net sold $731K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Amy L. Burroughs
- Employees:59
- HQ:Foster City, CA, US
- IPO:2021-02-05
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$731K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
Kuriakose EmilFirst filing | Chief Medical Officer | Sale | 942 | $50K | Apr 2 | SEC ↗ |
Burroughs Amy L.First filing | Chief Executive Officer | Sale | 14,583 | $681K | Mar 17 | SEC ↗ |